ARTICLE | Company News
Breath takeout gives Zambon lung transplant candidate, U.S. foothold
July 25, 2019 8:06 AM UTC
Italian pharma Zambon is acquiring Sofinnova Partners portfolio company Breath Therapeutics for €140 million ($156 million) up front to expand its respiratory pipeline and establish a foothold in the U.S.
Shareholders of Breath Therapeutics B.V. (Munich, Germany) are also eligible for up to €360 million ($401 million) in milestones...